Delivery Order SPE2DB25D3201-SPE2DB26FNNRH
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 23, 2025, for the supply of Isotretinoin 30 mg capsules (30-count units) with a ceiling value of $7,051.35. This competitively awarded, firm fixed-price delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 through December 2026. The place of performance is AmerisourceBergen's corporate...
- The Defense Logistics Agency (DLA) awarded a $1,567.08 delivery order to AmerisourceBergen Drug Corp on May 30, 2025, for the supply of Isotretinoin 40 mg capsules (30-count). This is a firm fixed price, competitively awarded contract with no set-aside designation, scheduled for completion by June 2, 2025. The order will be fulfilled from AmerisourceBergen's Conshohocken, Pennsylvania facility, where the company maintains its corporate headquarters and primary distribution operations. This...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on October 23, 2025, for the supply of Isotretinoin 40 mg capsules in quantities of 30 units. This is a firm fixed price delivery order with a ceiling value of $1,278.33, with an ultimate completion date of October 24, 2025. The contract carries no set-aside designation and was competitively awarded. The place of performance is located in Conshohocken, Pennsylvania, which serves as the company's corporate...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Isotretinoin 20 mg capsules (30-count units) with a ceiling value of $1,225.40. This is a firm fixed-price delivery order with no set-aside designation, awarded on September 5, 2025, with an ultimate completion date of September 8, 2025. The place of performance is located in Conshohocken, Pennsylvania, where AmerisourceBergen Drug Corp maintains its corporate headquarters. This...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,584.30 to AmerisourceBergen Drug Corp for Isotretinoin 20 mg capsules (30-count packaging) on September 8, 2025, with an ultimate completion date of September 9, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and is performed at the contractor's Conshohocken, Pennsylvania location. The award falls under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA...
- The Defense Logistics Agency awarded a $2,874.48 delivery order to AmerisourceBergen Drug Corp for the supply of Isotretinoin 30 mg capsules (30-count) on October 27, 2025, with an ultimate completion date of October 28, 2025. This competitively awarded, firm fixed-price contract is non-set-aside and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a child contract under AmerisourceBergen's larger Indefinite...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on October 27, 2025, for the supply of Isotretinoin 30 mg capsules (30-count) with a ceiling value of $2,548.37. This is a firm fixed-price delivery order with no set-aside designation, indicating it was awarded through open competition. The order is set for completion by October 28, 2025, and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. This delivery order is...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 24, 2025, for the supply of Isotretinoin 30 mg capsules in quantities of 30, with a ceiling value of $2,347.10. This is a firm fixed price delivery order with no set-aside designation, indicating competitive award. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, with an ultimate completion date of September 25, 2025. This delivery...
- The Defense Logistics Agency awarded a $1,029.92 delivery order to AmerisourceBergen Drug Corp on June 17, 2025, for the supply of Isotretinoin 40 mg capsules (30-count units). This is a firm fixed price, competitively awarded delivery order with no set-aside designation and an ultimate completion date of June 18, 2025. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, serves as a critical pharmaceutical distributor for federal medical procurement, particularly supporting...
- The Defense Logistics Agency awarded a $5,344.77 firm fixed-price delivery order to AmerisourceBergen Drug Corp on October 17, 2025, for the supply of Isotretinoin 30 mg capsules (30-count units). The contract, which is classified as a non-set-aside award, is scheduled for completion by October 20, 2025, and will be fulfilled from the contractor's Conshohocken, Pennsylvania facility. This delivery order is issued under AmerisourceBergen's broader Indefinite Delivery Contract with DLA Troop...
- SPE2DB25D3201Indefinite Delivery Contract
- SPE2DB25D3201-SPE2DB26FNNRHDelivery Order
The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp for Isotretinoin 40 mg capsules (30-count units) on October 27, 2025, with a ceiling value of $2,719.20 and an ultimate completion date of October 28, 2025. This is a firm fixed-price, competitively awarded delivery order with no set-aside designation. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a comprehensive pharmaceutical prime vendor agreement valued at $999,999,999.00 and extending through December 2026, which authorizes the company to supply pharmaceuticals and medical supplies to support military healthcare programs globally. AmerisourceBergen Drug Corp serves as a major pharmaceutical distributor for federal medical procurement, particularly supporting military and veteran healthcare systems through the DLA Medical Supply Chain. The company maintains an extensive portfolio of federal contracts covering a broad range of pharmaceutical products and medical commodities across multiple therapeutic domains. As a non-set-aside contractor, AmerisourceBergen has demonstrated its capability to compete and perform on federal procurement requirements, with delivery orders ranging significantly in value and scope to support Defense Health Agency, U.S. Coast Guard, and other government healthcare systems.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.7k | 10/27/25 |